H3K27M-specific Immune Effector Cells

· Shenzhen Geno-Immune Medical Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for H3K27M-specific Immune Effector Cells, covering 2026-03-30 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: H3K27M-specific Immune Effector Cells Targeting DMG/DIPG [Phase 1, Phase 2]